Medical Research
(H50)
IRS Verified
DX Registered
990 on File
CHRISTOPHER REEVE FOUNDATION A NEW JERSEY NONPROFIT CORPORATION
Financial strength (30%)
75/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$22.6M
Total Revenue
$16.4M
Total Expenses
$29.4M
Net Assets
59
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.0%
Fundraising Efficiency
723.3%
Operating Reserve
21.47x
Liability-to-Asset
5.0%
Revenue Diversification
99.4%
Executive Compensation
$1.4M
Compared with Peers
FY 2025
Compared with 35 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.0% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.0% | 9.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.0% | 0.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
723.3% | 1042.4% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.5 mo | 17.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
5.0% | 22.9% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.4% | 84.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
9.7% | 9.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
90.6% | 6.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
27.3% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $22.6M | $16.4M | $29.4M | 86.0% | 59 |
| 2024 | $20.6M | $8.6M | $23.1M | 87.3% | 0 |
| 2023 | $17.8M | $14.9M | $9.4M | 84.9% | 61 |
| 2022 | $16.2M | $15.1M | $7.9M | 85.2% | 56 |
| 2021 | $16.8M | $14.4M | N/A | — | 45 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.